Repligen (RGEN) Restructuring Costs (2012 - 2026)
Repligen (RGEN) reported Restructuring Costs of $1.5 million for Q1 2026, down 24.18% year-over-year from $2.0 million in Q1 2025, and down 24.18% on a QoQ basis from $2.0 million in Q1 2025.
Repligen (RGEN) has 5 years of Restructuring Costs data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Restructuring Costs fell 24.18% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 37.46% YoY) and the FY2014 annual result came in at $1.9 million, up 2032.89% from the prior year.
- Restructuring Costs slipped to $1.5 million in Q1 2026 per RGEN's latest filing, from $2.0 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $2.0 million in Q1 2025 and bottomed at $1.5 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2014 | 1.95 Mn |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 98,000.00 |
| Dec 31, 2013 | 45,000.00 |
| Sep 30, 2013 | 65,000.00 |
| Jun 30, 2013 | 35,000.00 |
| Mar 31, 2013 | -54,000.00 |
| Dec 31, 2012 | 267,000.00 |
| Sep 30, 2012 | 344,000.00 |